OpenGov, a leading provider of open-source technology solutions, has announced a successful funding round, raising an impressive $3,000,000. Founded in July 1997 as Versátil Sistemas, the company initially focused on creating tailored systems for the pharmaceutical industry. However, in 2009, the transition into OpenGov Soluções em Tecnologia Ltda. marked a significant shift towards open-source systems and the migration of proprietary technologies. The recent funding will enable OpenGov to further enhance its development of open-source applications, expand its migration services, and bolster technical support in information technology. With a team of highly qualified professionals certified in various fields such as Microsoft MCSE and Network Security MIT-USA, OpenGov is dedicated to simplifying technology for its clients in both the public and private sectors. The influx of capital will also support the company’s ongoing commitment to innovation, ensuring that they continue to provide cutting-edge solutions that meet the evolving needs of their diverse clientele. As organizations increasingly seek ways to optimize their operations and reduce reliance on proprietary systems, OpenGov stands ready to lead the charge in delivering accessible, efficient, and sustainable tech solutions. This funding milestone is not just a testament to the company's accomplishments but also a catalyst for further growth, setting the stage for future advancements and collaborations in the realm of open-source technology.
Opengov Secures $3 Million in Series A Funding for Tech Solutions and IT Services Expansion
Get the full OpenGov company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
EarthOptics
EarthOptics is transforming how the world understands and manages soil. By combining next-generation sensors, advanced algorithms, and carbon analytics, we’re building the Soil Cloud—a powerful data platform that empowers farmers to sustainably optimize their operations, increase yields, and feed a growing global population. Our technology delivers high-resolution insights into soil properties at scale, making a positive impact on both environmental health and farm profitability.
$110.0M Series c
today
Otomato.xyz
Meet your Smart DeFi assistant. One setup, zero dashboards. Get hyper-targeted updates on your positions, starting with HyperEVM. ✨
$2.0M Seed
today
Waypoint Bio
Waypoint Bio is a VC-backed biotech startup building the next generation of cell therapies for solid tumors.
$20.0M Series a
today
Crimson
Crimson’s IT recruitment services simplify the recruitment process, helping hiring managers find the best contract and permanent IT talent in established and emerging disciplines. Clients and candidates alike continue to choose Crimson because of three specific reasons: A commitment to keeping promises and delivering first time, supported by a £1M investment in relationship management technology. An unparalleled network and expert market insight from over 20 years’ sector experience. A world-beating level of friendly service borne out by a world-beating Net Promotor Score. Talk to us on 01675 466 477 and discover for yourself why candidates and hiring managers choose Crimson for their IT recruitment solutions.
$2.5M Seed
today
Asteromorph
We are a team of scientists and engineers working on building scientific superintelligence. Our discovery system - an orchestration of AI models designed to drive scientific progress as an independent architect - inspires breakthrough theses and develops them to robust statements with self-conducted experiments in both silicon and physical world.
$31.4M Seed
today
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | Waypoint Bio United States | Series a | $20.0M | today |
| 2 |  Default United States | Series a | $20.0M | today |
| 3 |  Abstract United States | Series a | $59.0M | 1d ago |
| 4 |  Pacifico Biolabs Germany | Series a | €7.0M | 1d ago |
| 5 |  Secretome Therapeutics United States | Series a | $30.0M | 1d ago |